Valion Bio Inc (VBIO) — Capital Reinvestment Ratio

Latest as of September 2025: 0.01x

Valion Bio Inc (VBIO) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($964.82K) in capital expenditures ($10.00K). See VBIO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$964.82K

USD

Capital Expenditures

$10.00K

USD

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for Valion Bio Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Valion Bio Inc from None to None. For live market cap and broader valuation context, see Valion Bio Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow